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Abstract The cell-free examination of the human insulin
receptor during biogenesis may provide a greater understanding
of the elements that contribute to the acquisition of receptor
function. The insulin receptor precursor components were
produced in a cell-free system and the insulin binding ability of
the [35S]methionine-labeled translation products was determined.
The processed proreceptor represented by a 190 kDa band was
retained on insulin-linked biotin-streptavidin agarose or an
insulin column. The insulin binding 190 kDa band migrated
slower than the non-binding 190 kDa band on SDS-PAGE which
suggests that covalent modifications account for these differ-
ences. The trypsin-digested product of the 190 kDa proreceptor
was also retained on insulin-linked biotin-streptavidin agarose,
however the K-subunit precursor was retained on insulin agarose
to a much lesser degree. We conclude that a significant fraction
of the processed, in vitro translated insulin proreceptor acquires
insulin binding ability.
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1. Introduction
The human insulin receptor (hINSR) is present on the cell
surface in an K2L2 heterotetrameric con¢guration linked by
disul¢de bonds. This quaternary structure of the fully func-
tional hINSR results from a series of post-translational proc-
essing steps which include N-linked and O-linked glycosyla-
tion, dimerization, proteolytic cleavage, and fatty acylation
[1,2]. Studies by others have demonstrated that insulin binding
induces intramolecular changes that activate the L-subunit of
an K-L heterodimer to phosphorylate tyrosine residues in the
cytoplasmic domain of the other K-L heterodimer which then
results in receptor activation [3]. This intramolecular interac-
tion underscores the importance of post-translational modi¢-
cations that yield the heterotetrameric con¢guration of the
hINSR on the cell surface. Therefore, studies that examine
the receptor in various stages of biogenesis may provide a
greater understanding of the elements that contribute to the
acquisition of receptor function. However, biosynthetic proc-
essing events occur rapidly in a cell, which makes in vivo
examination of receptor precursors at di¡erent stages of bio-
genesis di⁄cult. The in vitro translation systems have been
used to examine protein folding, subunit assembly and inter-
action with molecular chaperones [4^6]. In vitro translation of
the luciferase protein in reticulocyte lysate results in proper
protein folding and associated enzymatic activity [5,7]. The
eukaryotic rabbit reticulocyte system has been utilized to ex-
amine conformational status of the hINSR precursor compo-
nents but the functional examination of in vitro synthesized
and processed membrane-bound proteins have not been pre-
viously reported [8,9]. In this study, we present insulin binding
results of receptor precursors synthesized and processed in a
cell-free system.
2. Materials and methods
2.1. Materials
The pSP64 plasmid which contains the 4.6 kb hINSR cDNA was a
generous gift of Dr. Graeme Bell (Howard Hughes Medical Institute,
University of Chicago, IL, USA). The cDNA sequence encoding the
K-subunit of the hINSR (sequence 46^2246) was subcloned into a
pSP64polyA plasmid using appropriate restriction endonuclease sites,
AvrII and A£II [10]. Crystalline biosynthetic human insulin was
kindly provided by Dr. R. Chance of Eli Lilly Company (Indianap-
olis, IN, USA). The materials for the coupled transcription and trans-
lation reactions, and pancreatic microsomes were purchased from
Promega (Madison, WI, USA). Anti-hINSR antibody, a rabbit poly-
clonal antibody directed at amino acids 441^620 of the L-subunit of
the hINSR was obtained from Transduction Laboratories (Lexington,
KY, USA) [10]. The materials for lectin chromatography, insulin-
linked and monoclonal antibody-immobilized biotin-streptavidin
agarose, phenylmethylsulfonyl £uoride (PMSF) and aprotinin were
obtained from Sigma (St. Louis, MO, USA). Translation grade
[35S]methionine (1250 Ci/mmol), [3H]leucine (60 Ci/mmol) and
En[3H]ance were purchased from Dupont NEN (Boston, MA,
USA), and the Enhanced Chemiluminescence (ECL) detection system
was obtained from Amersham (Arlington Heights, IL, USA). A⁄-gel
15 resin and materials for polyacrylamide gel electrophoresis (PAGE)
were obtained from Bio-Rad (Richmond, CA, USA). All other chem-
icals were reagent grade.
2.2. Cell culture
IM-9 lymphocytes (ATCC, Rockville, MD, USA) were grown in
suspension using RPMI 1640 medium containing 25 mM HEPES and
10% fetal bovine serum and supplemented with 10 mg/ml L-glutamine.
Approximately 109 cells were washed several times in PBS, and solu-
bilized with 1% Triton X-100 in 50 mM HEPES, 150 mM NaCl
bu¡er, pH 7.6 containing 2 mM PMSF and 0.5 TIU/ml of aprotinin
for 30 min on ice. The solubilized extract which contained mature
insulin receptors was subsequently obtained by centrifugation at
16 000 g for 30 min at 4‡C.
2.3. Preparation of Xenopus egg extract (XEE)
This protocol was approved by the Laboratory of Animal Services
of the University of Hawaii-Manoa. Adult female Xenopus laevis were
obtained from Nasco (Fort Atkinson, WI, USA). The Xenopus eggs
were obtained from frogs by injection of 100 U of PMSG for oocyte
maturation followed by induced ovulation with an injection of 750 U
of hCG, 4^5 days following PMSG injection. Eggs were dejellied by
incubation for 10^20 min at room temperature in 2% L-cysteine-HCl,
pH 7.7 solution, washed with extraction bu¡er containing 100 mM
KCl, 0.1 mM CaCl2, 1 mM MgCl2, 50 mM sucrose, and 10 mM
HEPES-KOH, pH 7.7. About 1 ml of eggs were transferred to a
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1.5 ml microcentrifuge tube, and the eggs were covered with Nyosil
M20 oil (Nye Lubricants, New Bedford, MA, USA). After a 2 min
centrifugation at 2000 rpm, the supernatant bu¡er and the oil were
removed, the eggs crushed and the cytoplasm isolated by centrifuga-
tion for 15 min at 10 000 rpm in 4‡C. The middle layer extract was
collected by side-puncturing the tube with a needle [11]. The extract
was supplemented with cytochalasin B (50 mg/l) and aprotinin
(76 TIU/l), and centrifuged again for 5 min at 10 000 rpm. The middle
layer was again collected and treated with RNase A (0.1 mg/l) for
15 min in 10‡C to deplete endogenous mRNA. RNase was then in-
activated with RNase inhibitor (500 U/ml) and 1 mM DTT. The
extract was then supplemented with calf tRNA (100 Wg/l) and glycerol
(5%) or sucrose (250 mM) and aliquoted and stored at 370‡C for
later use.
2.4. In vitro transcription/translation and processing
The hINSR precursor and the K-subunit precursor of the hINSR
were synthesized in a cell-free coupled transcription and translation
system by adding 0.5 Wg of pSP64-hINSR or pSP64-polyAK-subunit
plasmid in a reaction that contained rabbit reticulocyte lysate, RNAse
inhibitor, methionine-free amino acid mixture, and SP6 RNA polym-
erase in a ¢nal volume of 25 Wl according to the manufacturer’s in-
structions [12]. The translation products were radiolabeled with
[35S]methionine (20 WCi/reaction) or [3H]leucine (5 WCi/reaction),
and post-translational processing was performed with the addition
of canine pancreatic microsomal membranes (2 EQ/25 Wl reaction)
or XEE (1.0^1.5 Wl/reaction). The coupled transcription and trans-
lation reactions were performed for 1.5 h at 30‡C [13].
Trypsin digestion of the in vitro translated precursor was performed
with the addition of 5 Wg/ml trypsin for 5 min at 4‡C. The digestion
was terminated with the addition of 0.5 M EDTA and aprotinin (0.5
TIU/ml).
2.5. Lectin and insulin a⁄nity chromatography
Approximately 2 ml of wheat germ agglutinin (WGA) lectin (8 mg)
coupled to agarose was packed into a 15 ml column. These columns
were prepared by washing with a non-denaturing detergent bu¡er,
bu¡er II (50 mM HEPES, 150 mM NaCl, 0.1% Triton X-100 bu¡er,
pH 7.6), followed by the addition of 0.01% sodium dodecyl sulfate
(SDS) to bu¡er II (bu¡er I) [14]. Approximately 2 mg/ml of solubi-
lized IM-9 cell extract containing the mature hINSR was diluted with
10-fold excess of bu¡er III (10 mM MgSO4 to bu¡er II) supplemented
with PMSF (2 mM) and aprotinin (0.5 TIU/ml) and passed over the
WGA lectin column, and the bound material eluted with 2 ml of
bu¡er III containing 0.3 M N-acetyl glucosamine.
Human insulin was dissolved in 0.1 M MOPS bu¡er, pH 7.5 or 6 M
urea in 0.1 M Na-phosphate bu¡er, pH 7.4 in a concentration of
40 mg/ml, and incubated with 2 ml of activated A⁄-gel 15 resin for
4 h at 4‡C. The e⁄ciency of insulin crosslinking to A⁄-gel 15 was
approximately 35%. BSA was similarly linked to the A⁄-gel 15 resin
and served as the non-speci¢c binding control column. Equally div-
ided aliquots of the WGA eluate and the in vitro translation reaction
mixture were applied to insulin-linked and BSA-linked columns in
separate experiments. Bound products were then eluted with 0.05 M
acetic acid, 1.0 M NaCl and 0.1% Triton X-100, pH 5 bu¡er, and the
columns washed with 50 volumes of 0.05 M Tris-HCl, 0.1% Triton
X-100, pH 7.4 bu¡er. A Tris-HCl bu¡er with 0.1% SDS was then used
to remove the remaining bound materials o¡ the columns.
Additionally, the in vitro synthesized, processed, and [3H]leucine-
labeled hINSR precursor components were incubated with insulin-
linked biotin or non-speci¢c goat, anti-mouse immunoglobulin-linked
biotin for 14 h at 4‡C. The bound products were then isolated with
the addition of streptavidin-linked agarose and the products released
with 4U sample bu¡er (see below).
2.6. SDS-polyacrylamide gel electrophoresis
The ¢nal products of in vitro translation and lectin and insulin
chromatography were mixed with sample bu¡er (2% SDS, 10% glyc-
erol, 0.002% bromophenol blue, 0.1 M DTT, and 0.01 M phosphate
bu¡er), boiled for 5 min and the receptor components were separated
by SDS-PAGE (7.5%) under reduced condition by the discontinuous
method of Laemmli [15]. Following electrophoresis, the radiolabeled
bands on gels were identi¢ed by autoradiography or £uorography
with Fuji Medical X-ray Film. The SDS-PAGE gels which contained
non-radiolabeled proteins were processed for immunoblot analysis as
described below.
2.7. Protein immunoblot analysis
Following SDS-PAGE, the non-radiolabeled proteins were trans-
ferred onto PVDF membranes using a Bio-Rad electroblotter for
45 min at 100 V in transfer bu¡er [50 mM Tris-HCl, 380 mM glycine,
0.1% SDS, and 20% methanol (v/v)]. The membranes were then in-
cubated with 5% non-fat dry milk in 0.1% Tween 20 and PBS
(PBS1T) bu¡er, pH 7.4 for 1 h at 23‡C, followed by incubation
with anti-insulin receptor antibody [1:250 dilution (v/v)] in PBS1T
bu¡er with 1% non-fat dry milk for 14 h at 4‡C. The membranes
were subsequently washed with 0.3% Tween 20, PBS bu¡er and in-
cubated with horseradish peroxidase-conjugated anti-rabbit goat anti-
body (1:1000 in PBS1T) for 1 h at 23‡C, and the immunocomplexes
identi¢ed by the ECL detection method.
3. Results and discussion
The acquisition of ligand binding ability of the hINSR dur-
ing biogenesis occurs by a conformational change within the
monomeric proreceptor prior to disul¢de-linked dimerization
[16]. To assess the post-translational processing events that
confer insulin recognition to the single-chain proreceptor, a
cell-free system was used to readily produce and identify the
precursor components. The insulin-linked columns used to
determine insulin binding function of the hINSR precursors
were ¢rst assessed for retention of mature insulin receptors.
IM-9 cells expressing high concentrations of cell surface
hINSR were processed by non-denaturing detergent extrac-
tion, and the receptors puri¢ed with WGA chromatography
[17]. The non-radiolabeled, WGA-puri¢ed material was ap-
plied to the insulin-linked or BSA-linked columns, and the
bound material eluted with 0.05 M Na-acetate bu¡er, pH 5
and 0.1% SDS bu¡er. The products o¡ the insulin and BSA
columns were then processed by SDS-PAGE and the mature
receptor identi¢ed by immunoblot analysis using an antibody
speci¢c for the 95 kDa L-subunit. Elution of WGA-puri¢ed
receptors o¡ the insulin column using Na-acetate bu¡er, pH
5.0 readily demonstrated the L-subunit, but the elution was
not complete since the 95 kDa band was additionally observed
in the detergent bu¡er eluate (Fig. 1). However, a large frac-
tion of mature receptors was observed in the £ow-through
fraction of the insulin column. The L-subunit 95 kDa band
was only detected in the £ow-through fraction of the BSA-
linked column, and not in the low pH or SDS eluate fractions.
These results validated the insulin column’s capacity to spe-
ci¢cally retain the hINSR.
To determine the insulin binding ability of the cell-free
translated and processed proreceptor, [35S]methionine-labeled
translation products were examined for retention on the in-
Fig. 1. Insulin column retention of mature hINSR isolated from
IM-9 lymphocytes. The WGA-puri¢ed hINSR from IM-9 cells was
examined for retention on insulin (I) or BSA (B) columns. The
£ow-through fraction, and both 0.05 M Na-acetate bu¡er, pH 5
and 0.1% SDS eluate fractions were examined by 6% SDS-PAGE
and immunoblot analysis using the anti-hINSR antibody and ECL
detection method.
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sulin column. Equal aliquots of the translation reaction mix-
ture were applied to the insulin-linked or BSA-linked A⁄-gel
15 columns, and the retained products were sequentially
eluted with Na-acetate bu¡er, pH 5 and 0.1% SDS bu¡er.
The radiolabeled 190 kDa and 160 kDa bands, which repre-
sent the processed proreceptor and the nascent precursor com-
ponents respectively, were primarily found in the £ow-through
fraction of both the insulin and BSA columns (Fig. 2, lanes 2
and 5). A 190 kDa band of reduced intensity was the only
radiolabeled band observed in the low pH eluate fraction of
the insulin column which suggested that a small fraction of
the processed 190 kDa component-bound insulin (lanes 3 and
6).
The low yield of the 190 kDa component with in vitro
translation and the insulin column retention of the 190 kDa
fraction required improved methods to isolate the N-linked
glycosylated 190 kDa processed proreceptor. We have recently
found that translocation and processing of the hINSR precur-
sor was enhanced by the addition of XEE as compared to
MM in the RRL translation reactions [12]. The processing
e⁄ciency of the combined RRL and XEE reactions was
near-complete, allowing for the exclusive production of the
190 kDa precursor component. Furthermore, the limitations
of the insulin-linked column method to examine ligand bind-
ing capacity of the in vitro translated and processed hINSR
precursor was overcome by the use of insulin-linked biotin-
streptavidin agarose matrices which allowed longer incubation
times. Incubation of combined RRL and XEE synthesized
product with insulin-linked biotin resulted in the isolation
with streptavidin agarose matrix of approximately 30^40%
of the radiolabeled 190 kDa bands of the total reaction mix-
ture (Fig. 3, top panel). Incubation of the reaction mixture
with immunoglobulin-linked biotin failed to produce any 190
kDa bands with streptavidin agarose adsorption (Fig. 3, bot-
tom panel). These results con¢rm the initial observation that
the in vitro synthesized and processed hINSR proreceptor
bind insulin. The hINSR undergoes proteolytic cleavage dur-
ing biogenesis to yield the K-L heterodimer. To determine if
proteolytic cleavage of the 190 kDa precursor component in-
creased ligand binding ability, the in vitro synthesized product
was digested with trypsin and incubated with insulin-linked
biotin. Trypsin treatment of the reaction mixture resulted in
incomplete digestion of the 190 kDa component and yielded a
small fraction of the 120 kDa band which represents the pre-
K-subunit (Fig. 3, top panel). Isolation of the insulin-linked
biotin-bound fraction identi¢ed a weak 120 kDa radiolabeled
band which also appeared to migrate slower than the non-
insulin-bound 120 kDa band. Due to the ine⁄ciency of tryptic
digestion, the percentage of the insulin binding component of
the 120 kDa band was di⁄cult to determine. However, the
results appeared similar to the 30^40% binding fraction seen
with the 190 kDa precursor.
Fig. 2. Insulin a⁄nity column processing of the in vitro synthesized
hINSR precursor. The pSP64-hINSR plasmid was transcribed with
SP6 RNA polymerase and the mRNA translated in a coupled sys-
tem with rabbit reticulocyte lysate. The translation products were la-
beled with [35S]methionine and co-translational processing per-
formed with the addition of canine pancreatic microsomes. Ligand
binding ability of proreceptor components was examined by applica-
tion to insulin- or BSA-linked A⁄-gel 15 columns as described in
Section 2. The translated products retained on the column were se-
quentially eluted with 0.05 M Na-acetate bu¡er, pH 5 and 0.1%
SDS bu¡er. The products in the original translation reaction and
the insulin column £ow-through, and Na-acetate and SDS eluates
were identi¢ed by 7.5% SDS-PAGE under reduced condition and
autoradiography. Lane 1: original translation reaction; lanes 2 and
5: column £ow-through; lanes 3 and 6: Na-acetate eluate; lanes 4
and 7: 0.1% SDS eluate.
Fig. 3. Insulin binding of the in vitro synthesized and trypsin-di-
gested hINSR precursor. The hINSR precursor components were
produced and labeled with [3H]leucine as described in Section 2.
Co-translational processing of the hINSR nascent precursor was
performed with the addition of XEE. Ligand binding ability of the
proreceptor components was examined by application to insulin-
linked biotin or immunoglobulin-linked biotin for 14 h at 4‡C. The
bound products were puri¢ed with the addition of streptavidin-
linked agarose, and the products released with SDS bu¡er. The
products were identi¢ed by 7% SDS-PAGE and £uorography. Tryp-
sin digestion of the hINSR precursor was performed after in vitro
translation with 5 Wg/ml trypsin for 5 min at 4‡C. Top panel: insu-
lin-linked biotin/streptavidin agarose (P) or supernatant (S). Bottom
panel: Ig-linked biotin/streptavidin supernatant.
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The fraction of the 190 kDa component that binds insulin
appears to migrate slower in SDS-PAGE than the non-bind-
ing fraction. This electrophoretic pattern suggests an approx-
imately 5 kDa increase in molecular mass of the ligand bind-
ing component which can only be attributed to covalent
modi¢cations. Since the SDS-PAGE is performed under re-
duced and denaturing conditions, disul¢de bridging or con-
formational changes would not account for this slower mi-
grating pattern. The co-translational N-linked glycosylation
of the hINSR precursor may account for this di¡erence.
The addition of core oligosaccharides to the nascent precursor
in the in vitro translation reactions is probably an incomplete
process. Full glycosylation of the K-subunit may result in
conformational changes that allow for the acquisition of lig-
and binding as well as the di¡erences in molecular mass [18].
Another consideration for this apparent increase in molecular
mass is the covalent modi¢cation of the hINSR precursor by
phosphorylation. The mature hINSR on the cell surface is
phosphorylated on serine and threonine residues in the basal
state, and autophosphorylated on tyrosine residues with insu-
lin stimulation [1]. Moreover, phosphorylation of proteins ac-
count for signi¢cant di¡erences in molecular mass as demon-
strated for IRS-1 [19]. Ester-linked phosphorylations may
occur during biogenesis of the hINSR, accounting for the
di¡erence in molecular size. Tyrosine phosphorylation could
also occur during biosynthesis and possibly be removed by
cytoplasmic phosphatases prior to insertion into the plasma
membrane. These possibilities would suggest that phospho-
rylation plays a role in biogenesis or regulates acquisition of
receptor function. Other covalent modi¢cations such as myr-
istylation also need to be considered as well as modi¢cations
that have yet to be de¢ned [20].
Combined RRL and XEE synthesis and insulin binding
studies of the K-subunit precursor demonstrated results that
were quite di¡erent than that observed of the 190 kDa pro-
receptor and the trypsin-digested 120 kDa product (Fig. 4).
The 120 kDa K-subunit band showed a markedly reduced
insulin binding fraction which was estimated to be less than
10% of the synthesized 120 kDa band. However, the insulin
binding fraction showed a similarly slower migration pattern
with protein electrophoresis. Thus, the insulin binding com-
ponent of the hINSR precursor has an increased apparent
molecular mass which suggest that the covalent modi¢cation
accounting for this change allows for the acquisition of ligand
binding.
The demonstration of the in vitro translated and processed
proreceptor to bind insulin raised the possibility that the ter-
tiary conformational status of the ligand binding precursor
component is di¡erent from that of the predominant, non-
ligand binding component. The hINSR precursor produced
in the cell-free rabbit reticulocyte lysate system has been pre-
viously identi¢ed to be in monomeric conformation [8]. The
possibility that the ligand binding component of the 190 kDa
hINSR precursor is processed to a quaternary homodimeric
form required the examination of the insulin column eluates
under non-reducing condition. Radiolabeled bands larger
than 200 kDa were not observed when analyzed on a 6%
non-reduced gel which suggests the absence of multimeric
proreceptor components (data not shown). Thus, the ligand
binding 190 kDa component of the cell-free produced hINSR
precursor is a monomer.
This study demonstrate that proteolytic cleavage to sepa-
rate the K-subunit from the L-subunit of the in vitro produced
hINSR precursor does not appear to enhance or reduce in-
sulin binding capacity, and production of the insulin binding
subunit alone results in an K-subunit fraction with reduced
binding capacity. This ligand binding fraction of the hINSR
precursor suggests that tertiary changes occur with cell-free
translation which allows for proper conformational status
for insulin binding. The in vitro methods used in this study
do not entirely reproduce cellular processing, but many cyto-
plasmic and secreted proteins synthesized with this system are
completely processed and functionally active. This study uti-
lizing cell-free methods o¡ers an initial attempt at identifying
the early stages of functional acquisition of membrane-bound
proteins such as the hINSR which undergo extensive post-
translational modi¢cations. The acquisition of function of
the hINSR occurs with co-translational processing, and opti-
mal or full functional status of the receptor is conferred by
extensive post-translational modi¢cations. The identi¢cation
of mutations of the insulin receptor that alter biosynthetic
processing and translocation to the plasma membrane result-
ing in decreased cell surface receptors further underscore the
importance of modi¢cations that yield the heterotetrameric
con¢guration of the hINSR on the cell surface [18,21,22].
The demonstration of ligand binding ability of the monomeric
proreceptor elicits consideration of other receptor functions
such as ligand-induced dimerization, autophosphorylation,
and tyrosine kinase activation which may be acquired with
early biosynthetic processing. These functional characteristics
can be readily examined with in vitro translation methods,
and possibly yield a better understanding of receptor structure
changes that result in acquisition of function.
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